Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1957 Oct;36(10):1508–1515. doi: 10.1172/JCI103547

Overproduction of Uric Acid as the Cause of Hyperuricemia in Primary Gout

James B Wyngaarden 1,2
PMCID: PMC1072750  PMID: 13475488

Full text

PDF
1508

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BENEDICT J. D., KALINSKY H. J., SCARRONE L. A., WERTBEIM A. R., STETTEN D., Jr The origin of urinary creatine in progressive muscular dystrophy. J Clin Invest. 1955 Jan;34(1):141–145. doi: 10.1172/JCI103057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. BENEDICT J. D., KALINSKY H. J., SCARRONE L. A., WERTBEIM A. R., STETTEN D., Jr The origin of urinary creatine in progressive muscular dystrophy. J Clin Invest. 1955 Jan;34(1):141–145. doi: 10.1172/JCI103057. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BENEDICT J. D., ROCHE M., YU T. F., BIEN E. J., GUTMAN A. B., STETTEN D., Jr Incorporation of glycine nitrogen into uric acid in normal and gouty man. Metabolism. 1952 Jan;1(1):3–12. [PubMed] [Google Scholar]
  4. BENEDICT J. D., YU T. F., BIEN E. J., GUTMAN A. B., STETTEN D., Jr A further study of the utilization of dietary glycine nitrogen for uric acid synthesis in gout. J Clin Invest. 1953 Aug;32(8):775–777. doi: 10.1172/JCI102791. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. BIEN E. J., ZUCKER M. Uricolysis in normal and gouty individuals. Ann Rheum Dis. 1955 Dec;14(4):409–411. doi: 10.1136/ard.14.4.409. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. BISHOP C., RAND R., TALBOTT J. H. Rate of conversion of isotopic glycine to uric acid in the normal and gouty human and how this is affected by vitamin E and folic acid. Metabolism. 1955 Mar;4(2):174–182. [PubMed] [Google Scholar]
  7. BUZARD J., BISHOP C., TALBOTT J. H. The fate of uric acid in the normal and gouty human being. J Chronic Dis. 1955 Jul;2(1):42–49. doi: 10.1016/0021-9681(55)90106-5. [DOI] [PubMed] [Google Scholar]
  8. FRIEDMAN M., BYERS S. O. Increased renal excretion of urate in young patients with gout. Am J Med. 1950 Jul;9(1):31–34. doi: 10.1016/0002-9343(50)90005-2. [DOI] [PubMed] [Google Scholar]
  9. HEINRICH M. R., WILSON D. W. The biosynthesis of nucleic acid components studied with C14. I. Purines and pyrimidines in the rat. J Biol Chem. 1950 Oct;186(2):447–460. [PubMed] [Google Scholar]
  10. MULLER A. F., BAUER W. Uric acid production in normal and gouty subjects, determined by N15 labeled glycine. Proc Soc Exp Biol Med. 1953 Jan;82(1):47–50. doi: 10.3181/00379727-82-20019. [DOI] [PubMed] [Google Scholar]
  11. Robinson C. V. Windowless, Flow Type, Proportional Counter for Counting C14. Science. 1950 Aug 18;112(2903):198–199. doi: 10.1126/science.112.2903.198. [DOI] [PubMed] [Google Scholar]
  12. SEEGMILLER J. E., LASTER L., STETTEN D., Jr Incorporation of 4-amino-5-imidazolecarboxamide-4-C13 into uric acid in the normal human. J Biol Chem. 1955 Oct;216(2):653–662. [PubMed] [Google Scholar]
  13. SIROTA J. H., YU T. F., GUTMAN A. B. Effect of benemid (p-[di-n-propylsulfamyl]-benzoic acid) on urate clearance and other discrete renal functions in gouty subjects. J Clin Invest. 1952 Jul;31(7):692–701. doi: 10.1172/JCI102651. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. STETTEN D., Jr Recent contributions to the understanding of the metabolic defect in gout. Geriatrics. 1954 Apr;9(4):163–171. [PubMed] [Google Scholar]
  15. WYNGAARDEN J. B. Intermediary purine metabolism and the metabolic defects of gout. Metabolism. 1957 May;6(3):244–268. [PubMed] [Google Scholar]
  16. WYNGAARDEN J. B., SEGAL S., FOLEY J. B. Physiological disposition and metabolic fate of infused pentoses in man. J Clin Invest. 1957 Oct;36(10):1395–1407. doi: 10.1172/JCI103539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. WYNGAARDEN J. B., STETTEN D., Jr Uricolysis in normal man. J Biol Chem. 1953 Jul;203(1):9–21. [PubMed] [Google Scholar]
  18. YU T. F., SIROTA J. H., GUTMAN A. B. Effect of phenylbutazone (3,5 dioxo-1,2-diphenyl-4-n-butylpyrazolidine) on renal clearance of urate and other discrete renal functions in gouty subjects. J Clin Invest. 1953 Nov;32(11):1121–1132. doi: 10.1172/JCI102836. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES